Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline: Cytoparin-study postponed

Feb 7 (Reuters) - Corline Biomedical AB  CLBIO.ST : 
    * Cytoparin-study postponed 
    * Initially study was planned to start at year-end 2016/beginning of 2017 
    * Nordic Pancreas and Islet Transplantation Group, which recommended to pause the study, 
wants study leaders to present data that is basis for Medical Products Agency (Läkemedelsverket) 
and Etikprövningsnämnden's approval and justify study is carried out  
 
Source text for Eikon:  ID:nGNE3zb57w  
Further company coverage:  CLBIO.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Corline Biomedical AB

See all news